Celltrion will look for partners in new drug development, contract manufacturing and supply chains at CPHI Worldwide in Milan (Oct 6-8).

- Celltrion will participate in CPHI Worldwide in Milan from Oct. 6-8.
- Event is in its 37th year and expected to attract over 60,000 professionals from about 2,400 companies in 170 countries.
- Celltrion aims to partner in oncology, obesity/metabolic diseases, and autoimmune diseases.
- The company plans to emphasize antibody drug development and manufacturing capacity, plus CDMO partnerships.
- Booth area at the event is about 152 square meters.
